Attovia Therapeutics, Inc. (ATTO) stock
ATTONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026
$15.53+0.67 (+4.51%)
Close on Nov 18, 2026Market cap $708.96MP/E –Yield –
Attovia Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Attovia Therapeutics's total assets was $411.82M at Sep 30, 2026. For fiscal 2025 it was $165.89M.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $165.89M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $411.82M | – |
| Q2 FY2026 | Jun 30, 2026 | $128.35M | – |
| Q4 FY2025 | Dec 31, 2025 | $165.89M | – |
See a number that looks wrong?